Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.385 USD | +3.56% | +1.60% | -46.64% |
May. 30 | Evercore ISI Cuts Price Target on Editas Medicine to $7 From $15, Maintains In Line Rating | MT |
May. 14 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.64% | 428M | |
+46.11% | 54.63B | |
-6.94% | 39.92B | |
+37.07% | 38.82B | |
+13.34% | 26.86B | |
-11.17% | 26.22B | |
-21.73% | 18.78B | |
+25.86% | 12.21B | |
+0.63% | 12.16B | |
+25.80% | 11.94B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Barclays Adjusts Price Target on Editas Medicine to $11 From $10, Maintains Equal-Weight Rating